These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21902297)

  • 1. Eldecalcitol: a review of its use in the treatment of osteoporosis.
    Sanford M; McCormack PL
    Drugs; 2011 Sep; 71(13):1755-70. PubMed ID: 21902297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spotlight on eldecalcitol in osteoporosis.
    Sanford M; McCormack PL
    Drugs Aging; 2012 Jan; 29(1):69-71. PubMed ID: 22191725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eldecalcitol for the treatment of osteoporosis.
    Matsumoto T; Endo I
    Drugs Today (Barc); 2012 Mar; 48(3):189-96. PubMed ID: 22462038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eldecalcitol increases bone mineral density in Chinese osteoporotic patients without vitamin D or calcium supplementation.
    Jiang Y; Tang H; Ma X; Cheng Q; Lin H; Jin X; Zhang Z; Yu W; He S; Kobayashi T; Uehara S; Matsumoto T; Xia W
    J Bone Miner Metab; 2019 Nov; 37(6):1036-1047. PubMed ID: 31087185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eldecalcitol is superior to alfacalcidol in maintaining bone mineral density in glucocorticoid-induced osteoporosis patients (e-GLORIA).
    Matsumoto T; Yamamoto K; Takeuchi T; Tanaka Y; Tanaka S; Nakano T; Ito M; Tomomitsu T; Hirakawa A; Soen S
    J Bone Miner Metab; 2020 Jul; 38(4):522-532. PubMed ID: 32140784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of osteoporosis with eldecalcitol, a new vitamin D analog: a comprehensive review and meta-analysis of randomized clinical trials.
    Xu Z; Fan C; Zhao X; Tao H
    Drug Des Devel Ther; 2016; 10():509-17. PubMed ID: 26869769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures--a randomized, active comparator, double-blind study.
    Matsumoto T; Ito M; Hayashi Y; Hirota T; Tanigawara Y; Sone T; Fukunaga M; Shiraki M; Nakamura T
    Bone; 2011 Oct; 49(4):605-12. PubMed ID: 21784190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eldecalcitol for the treatment of osteoporosis.
    Noguchi Y; Kawate H; Nomura M; Takayanagi R
    Clin Interv Aging; 2013; 8():1313-21. PubMed ID: 24101867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Frontiers in vitamin D; basic research and clinical application. Eldecalcitol: the effect on bones and calcium metabolism].
    Endo I; Matsumoto T
    Clin Calcium; 2011 Nov; 21(11):103-10. PubMed ID: 22040826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eldecalcitol: newly developed active vitamin D(3) analog for the treatment of osteoporosis.
    Hagino H
    Expert Opin Pharmacother; 2013 Apr; 14(6):817-25. PubMed ID: 23477453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current Topics on Vitamin D. Treatment of osteoporosis with eldecalcitol: Its therapeutic efficacy and adverse effect on renal function].
    Takeuchi Y
    Clin Calcium; 2015 Mar; 25(3):425-32. PubMed ID: 25716816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional and potent roles of the 3-hydroxypropoxy group provide eldecalcitol's benefit in osteoporosis treatment.
    Ono Y
    J Steroid Biochem Mol Biol; 2014 Jan; 139():88-97. PubMed ID: 24139874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between the effect of eldecalcitol and serum 25(OH)D level.
    Takano T; Kondo S; Saito H; Matsumoto T;
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():124-7. PubMed ID: 24240066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of eldecalcitol and alfacalcidol on bone and calcium metabolism.
    Matsumoto T; Takano T; Yamakido S; Takahashi F; Tsuji N
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):261-4. PubMed ID: 20298784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety and effectiveness profile of eldecalcitol in a prospective, post-marketing observational study in Japanese patients with osteoporosis: interim report.
    Saito H; Kakihata H; Nishida Y; Yatomi S; Nihojima S; Kobayashi Y; Tabata H; Nomura M
    J Bone Miner Metab; 2017 Jul; 35(4):456-463. PubMed ID: 27699492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further significant effects of eldecalcitol on bone resorption markers and bone mineral density in postmenopausal osteoporosis patients having undergone long-term bisphosphonate treatment.
    Iba K; Sonoda T; Takada J; Dohke T; Yamashita T
    J Bone Miner Metab; 2017 Mar; 35(2):171-176. PubMed ID: 26832388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eldecalcitol reduces osteoporotic fractures by unique mechanisms.
    Kondo S; Takano T; Ono Y; Saito H; Matsumoto T
    J Steroid Biochem Mol Biol; 2015 Apr; 148():232-8. PubMed ID: 25625663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Frontiers in vitamin D; Basic research and clinical application. The effects of eldecalcitol on bone mineral density and fracture prevention--Post hoc analysis].
    Hagino H
    Clin Calcium; 2011 Nov; 21(11):111-8. PubMed ID: 22040827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D3 analogs for the treatment of osteoporosis.
    Hagino H
    Can J Physiol Pharmacol; 2015 May; 93(5):327-32. PubMed ID: 25853632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eldecalcitol reduces the risk of severe vertebral fractures and improves the health-related quality of life in patients with osteoporosis.
    Hagino H; Takano T; Fukunaga M; Shiraki M; Nakamura T; Matsumoto T
    J Bone Miner Metab; 2013 Mar; 31(2):183-9. PubMed ID: 23129180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.